Rapamycin in humans
I'm cautious on pharmaceuticals but am considering Rapamycin. Downsides are cost, difficulty to source and potential side effects (some people suffer from stomach issues IIRC). So balancing that I'm looking at potential benefits, aging being the benefit. Let's take this explanation of the benefits as an example, in particular
It has been known since the 1930s that caloric restriction extends lifespan and slows aging. Rapamycin could be characterized as caloric restriction in a pill. In a mouse study discussed in the "Cardiomyopathy" section, rapamycin had similar effect in aged mice as 40% caloric restriction in restoring the dysfunction of old hearts to normal function of young hearts.
Now separately we know that research has determined that caloric restriction does not have the effect for humans/chimps that you see with shorter lived species in life extension. It can increase health span (e.g. making you less prone to heart disease) but it won't add years to your life. AFAIK the Rapamycin studies have been done on mice and dogs which have a much shorter life span than humans.
Anybody have any data that says otherwise? If the main effect is to decrease TOR, well there are other ways to do that (periodic fasting which also has other benefits).
So at the moment I'm remaining skeptical of the benefit of Rapamycin in humans, adding in the other difficulties I'm holding off using it, but am open to research and evidence to the contrary.
-
Hi Dan,
I'm interested in Rapamycin as well, and just took the plunge and ordered a bottle.
I also take Metformin, and supplement with NMN (NAD precursor), ubquinol, quercetin, ptersostilbene, cruciferous veggie complex, Transfer Factor Multi-immune, astaxanthin, tocotrienol complex, turmeric, low dose Naltrexone, and a low dose of Nature-Throid. I don't go to doctors (formerly worked as an RN), and practice intermittent fasting most days. I order all my own stuff, and stopped going to doctors after having to "fix" a rheumatoid type nodule with topical tacrolimus cream (its an immunosuppressant like Rapo), and Minocycline , when all the doctor could offer was surgery~no thanks!
-
I am very suspicious of the lifespan vs. healthspan dichotomy that Dan states above. I believe it is a cop-out employed by age-treatment researchers to convince the FDA and NIH that they are working to improve a patient's health (which the NIH funds) rather than making the patient live longer (which the NIH refuses to fund). Why wouldn't a significant improvement in health make a test animal (or human) live longer? It makes no sense.
-
As you say, "Their messaging is that they work on health span, not life, and that's what they use in their funding pitches." That's exactly my point. It is not in the narrow interest of age-treatment researchers to admit to their funding agencies that increasing healthspan will tend to increase lifespan. Further, before one can actually investigate any effects on maximum lifespan, one must have a population of extremely old individuals that are in excellent health, and presently there are none. The extremely old tend to die of amyloid buildup leading to organ failure. One cannot make statistical arguments about the mean when there are no statistics. It seems obvious to me that an increase in healthspan will bring with it an increase in lifespan, cop-outs to funding agencies notwithstanding.
-
OK, your point is that we should shut up about work on healthspan probably increasing the maximum lifespan, because it gets in the way of desirable funding. I can agree with that, but such blatant misrepresentation in the interest of funding bothers me. It makes me wonder where else anti-aging researchers are willing to fudge the truth.
-
I think this is related to subject of this thread.
There is an amendment (notified by email today) in the order of intervention with more focus on metformin as both AMPK activator and mTOR inhibitor (vs rapamycin).
I report the note from Faloon got a coupe of days ago:
"...Our investigations and partial validations resulted in the dissemination of the following multi-step approach to biological age reversal at RAADfest:
Step 1: Inhibit mTOR and induce autophagy with rapamycin (or AMPK nutrients
and/or intermittent fasting and/or calorie restriction)
Step 2: Repair cellular DNA by boosting NAD+
Step 3: Purge senescent cells using two doses of dasatinib + quercetin
Step 4: Systemic rejuvenation with young plasma and/or stem cells
We are amending this sequential order in this email.
Based on ongoing clinical research, we believe most of you are already sufficiently inhibiting mTOR with metformin and/or nutrients like gynostemia leaf extract and hesperidin (found in the AMPK Activator nutrient formula).
Low-calorie diets and exercise also indirectly suppress mTOR (via activation of cellular AMPK).
So as of this date, we are revising the age-reversal protocol as follows:
Step 1: Inhibit mTOR/induce autophagy with metformin
(or AMPK nutrients)
Step 2: Repair cellular DNA by boosting NAD+
Step 3: Purge senescent cells using two doses of dasatinib + quercetin
Step 4: Systemic rejuvenation with young plasma and/or stem cells..."Beneficial effects on humans and differentiating between metformin and rapamycin need to be assessed, but it seems established the mechanisms are different. I understand rapamycin is directly inhibiting mTORC1 (chronic use might also result in inhibiting mTORC2 though which might not be good). Other molecules such as aspirin and metformin feature an indirect inhibition of mTORC1. Metformin seems to regulate REDD1 which promotes TSC2 which leads to inhibit mTORC1 and this independently from the metformin AMPK activation path (e.g. see Kalender et al 2010).
Any comment?
-
Well, I stopped taking PtC and ALC because of their connection to TMAO production in the gut. http://www.clevelandheartlab.com/blog/choline-tmao-heart-health/ I'm not sure whether this applies to vegans such as myself though.) I don't feel anything from ubiquinol at a dose of 100mg or NR at 250. How much does it take to feel it?